López-DÃaz de Cerio, A.; Perez-Estenaga, I.; Inoges, S.; Abizanda, G.; Gavira, J.J.; Larequi, E.; Andreu, E.; Rodriguez, S.; Gil, A.G.; Crisostomo, V.;
et al. Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics 2021, 13, 1269.
https://doi.org/10.3390/pharmaceutics13081269
AMA Style
López-DÃaz de Cerio A, Perez-Estenaga I, Inoges S, Abizanda G, Gavira JJ, Larequi E, Andreu E, Rodriguez S, Gil AG, Crisostomo V,
et al. Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics. 2021; 13(8):1269.
https://doi.org/10.3390/pharmaceutics13081269
Chicago/Turabian Style
López-DÃaz de Cerio, Ascensión, Iñigo Perez-Estenaga, Susana Inoges, Gloria Abizanda, Juan José Gavira, Eduardo Larequi, Enrique Andreu, Saray Rodriguez, Ana Gloria Gil, Verónica Crisostomo,
and et al. 2021. "Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy" Pharmaceutics 13, no. 8: 1269.
https://doi.org/10.3390/pharmaceutics13081269
APA Style
López-DÃaz de Cerio, A., Perez-Estenaga, I., Inoges, S., Abizanda, G., Gavira, J. J., Larequi, E., Andreu, E., Rodriguez, S., Gil, A. G., Crisostomo, V., Sanchez-Margallo, F. M., Bermejo, J., Jauregui, B., Quintana, L., Fernández-Avilés, F., Pelacho, B., & Prósper, F.
(2021). Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy. Pharmaceutics, 13(8), 1269.
https://doi.org/10.3390/pharmaceutics13081269
